Iqvia leads $14m investment round in patient engagement app

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/DGLimages)
(Image: Getty/DGLimages)

Related tags: IQVIA, patient engagement, Real world data, Oncology, Artificial intelligence, machine learning

Belong.Life raises $14m as part of a Series B funding round with plans to expand its patient engagement platform, using and complementing Iqvia’s solutions “to transform patient engagement,” says Iqvia VP.

Belong.Life yesterday announced that it has completed a $14m Series B fundraising round. Iqvia​ led the funding round and was joined by The Group Ventures and other existing investors.

The company's mobile app "Belong – Beating Cancer Together," is a social network and navigator app for cancer patients, caregivers, and health care professionals. Through the app, the Belong community can anonymously receive and share clinical information.

The funds will be used to develop the mobile app and the company’s new Belong Patient Engagement Platform (PEP), which provides patients, payers, providers, and life science companies with configurable patient engagement tools, navigation, and management services.

AJ Ploszay, PhD, vice president of digital strategy for global technology solutions, Iqvia, said the investment in Belong is part of the company’s strategy “to identify and accelerate disruptive technologies that can improve health care.”

“While maintaining every user’s complete anonymity, Belong’s Patient Powered Network gives researchers access to real world data that provides crucial insight into patient experiences,”​ a company representative from Belong told us. “PEP leverages AI and our proprietary machine learning technology to provide a hyper personalized patient engagement and research platform.”

The app is designed to improve patient engagement, education, compliance, satisfaction, auto-care coordination, and efficiency, they explained. As per the company’s relationship with Iqvia, the representative said more will be shared at a later stage.

“Through its unique patient engagement platform with machine learning and artificial intelligence capabilities, Belong can utilize and complement Iqvia’s solutions to transform patient engagement,”​ Ploszay told us.

“The health care industry is increasing its focus on patient centricity, engagement, and experience, however, engaging with patients comes with many challenges, including regulations, operational challenges, user acquisition and retention and creating educational content,”​ he added.

“Iqvia in partnership with Belong believes with our combined domain expertise we may be able to provide a solution that finally meets those needs.”

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us


View more